TOP NEWS: AstraZeneca's, Amgen's Tezspire pre-filled pen wins approval
02 Febbraio 2023 - 03:50PM
Alliance News
eneca PLC and
Amgen Inc on Thursday said their severe asthma drug Tezspire has
been approved in the form of a pre-filled pen by the US Food &
Drug...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Grafico Azioni Astrazeneca (LSE:AZN)
Storico
Da Feb 2023 a Mar 2023
Grafico Azioni Astrazeneca (LSE:AZN)
Storico
Da Mar 2022 a Mar 2023